RxDoctor Payments Data

Rachel Savage, PA

Physician Assistant · Lafayette, INNPI 1356391031

Payments from drug & device makers

$869in general payments, 2019–2025

Across 41 payments — averaging $21.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$314
  • Astellas Pharma US Inc$181
  • AbbVie$94
  • Sumitomo Pharma America, Inc.$88
  • Urovant Sciences Inc$50
  • Myovant Sciences Inc.$42
  • plus $100 from 6 others

What the payments were for

  • Food & beverage$77789%
  • Education$9211%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$869 in reported general payments places this provider in the 70th percentile of 1,955 physician assistant providers in Indiana.

See all physician assistant providers in Indiana

Medicare billing

Part B allowed, 2024
$64,986
Medicare patients
420
Services billed
1,293

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron235$188,275
GemtesaVibegron56$35,624
Mirabegron ErMirabegron33$15,602
Tamsulosin Hcl379$6,544
Estradiol61$3,488
Trospium Chloride32$1,741
Finasteride140$1,478
Cephalexin196$1,303
Solifenacin Succinate28$1,266
Oxybutynin Chloride ErOxybutynin Chloride68$1,155
Trimethoprim22$894
Dutasteride17$726
NitrofurantoinNitrofurantoin Macrocrystal25$606
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst30$309
Alfuzosin Hcl ErAlfuzosin Hcl12$297

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$181$188,275235 claims
Sumitomo Pharma America, Inc.Gemtesa$88$35,62456 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,955 physician assistant providers in Indiana.

Other physician assistant in Lafayette

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →